Did Nano Labs provide any guidance or outlook for the second half of 2025 or FY 2025, and what does that imply for future performance?
Guidance Verdict: In the AugustâŻ15 release NanoâŻLabs disclosed only its unaudited H1â2025 numbers; the filing contains no explicit revenue, earningsâperâshare or cashâflow outlook for the second half of 2025 or for the full FYâŻ2025. The companyâs commentary is limited to operational highlights and a statement that âthe business remains wellâpositioned to capture growth in WebâŻ3.0 infrastructure,â but no forwardâlooking quantitative targets were supplied.
Implication for Performance & Trading:
The absence of a formal outlook injects a degree of uncertainty into the equityâs shortâterm narrative. From a fundamental standpoint, investors must now rely on the H1â2025 results (e.g., YoY revenue growth, margin trends, cash runway) and macro drivers such as WebâŻ3.0 adoption rates, regulatory sentiment in HongâŻKong/US, and the broader techâsector risk appetite. If the halfâyear metrics beat consensus, the market may price in âimplicit upsideâ and push the stock higher on momentum; conversely, any shortfall could trigger a sellâoff given the lack of a reassuring guidance cushion.
From a technical angle, NA has been trading near its 50âday SMA with modest upward bias. The next key levels are the breakout zone around $12.50â$13.00 (resistance) and the support at $11.20 (the recent trough). In the absence of guidance, a watchâlist approach is prudent: consider entering a long position only on a clear bullish catalyst (e.g., positive analyst note, partnership announcement, or a break above $13.00 on strong volume). A stopâloss just below $11.20 can protect against downside if the market interprets the guidance void as a risk flag. Shortâterm traders should also monitor the options market for skewâelevated implied volatility may signal that participants are pricing in earningsârelated risk for the upcoming H2â2025 update.